Department of Ophthalmology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Department of Ophthalmology, Orlando VA Medical Center, Orlando, Florida, USA.
Br J Ophthalmol. 2018 May;102(5):654-658. doi: 10.1136/bjophthalmol-2017-310681. Epub 2017 Aug 26.
Orbital exenteration is a disfiguring procedure reserved for life-threatening malignancies. This study examines the clinical course and outcomes of a large series of patients who underwent orbital exenteration for malignant periocular neoplasms.
This is a retrospective review of patients who underwent orbital exenteration from 1 July 2005 to 30 June 2015 at four tertiary referral centres in the USA, Australia and Canada. Demographics, indication for surgery, pathology, surgical technique, reconstruction type and outcomes were reviewed.
Orbital exenteration was performed on 102 patients. The mean age at surgery was 67.5 years. The most common malignant tumours encountered were squamous cell carcinoma, melanoma and basal cell carcinoma. Seventy-six patients (75%) underwent reconstruction with a local myocutaneous flap, twelve with partial-thickness skin grafts (PTSG), or split skin graft, two had a free flap, and one had a dermis fat graft. Sixteen patients had combined procedures of two of the above. Complete removal of the tumour was achieved with clear margins in 81 cases. Of all patients, 72% were alive at 48 months or more.
The majority of orbital exenterations performed in this series were secondary to periocular malignancies with unsuccessful/insufficient previous treatments. Regional myocutaneous flaps, PTSG, full-thickness skin grafts and dermis fat grafts were all highly effective and durable reconstructive options, and were able to withstand radiation therapy without complications.
眼眶内容剜除术是一种用于危及生命的恶性肿瘤的毁容手术。本研究检查了在四个美国、澳大利亚和加拿大的三级转诊中心接受眼眶内容剜除术治疗恶性眼周肿瘤的大量患者的临床过程和结果。
这是对 2005 年 7 月 1 日至 2015 年 6 月 30 日期间在美国、澳大利亚和加拿大的四个三级转诊中心接受眼眶内容剜除术的患者进行的回顾性研究。回顾了患者的人口统计学、手术适应证、病理学、手术技术、重建类型和结果。
对 102 例患者进行了眼眶内容剜除术。手术时的平均年龄为 67.5 岁。最常见的恶性肿瘤是鳞状细胞癌、黑色素瘤和基底细胞癌。76 例(75%)患者行局部肌皮瓣重建,12 例患者行部分厚度皮肤移植(PTSG)或皮片移植,2 例患者行游离皮瓣移植,1 例患者行真皮脂肪移植。16 例患者联合上述两种方法进行手术。81 例患者肿瘤完全切除,切缘无肿瘤。所有患者中,72%的患者在 48 个月或更长时间后存活。
本系列中进行的大多数眼眶内容剜除术是由于眼周恶性肿瘤,且之前的治疗不成功/不充分。区域性肌皮瓣、PTSG、全厚皮片和真皮脂肪移植都是非常有效和持久的重建选择,能够耐受放疗而无并发症。